1 ? O43 Dose finding study of gadopiclenol, a new macrocyclic gadolinium-based contrast agent (GBCA), in MRI of central nervous system

Date 21/09/2019
Time 16:03 - 16:11
Location Meeting room 3
Speaker(s) ANZALONE N.